BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33667680)

  • 21. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors.
    Bilensoy E; Sarisozen C; Esendağli G; Doğan AL; Aktaş Y; Sen M; Mungan NA
    Int J Pharm; 2009 Apr; 371(1-2):170-6. PubMed ID: 19135514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chondroitin sulphate decorated nanoparticulate carriers of 5-fluorouracil: development and in vitro characterization.
    Yadav AK; Agarwal A; Jain S; Mishra AK; Bid H; Rai G; Agrawal H; Agrawal GP
    J Biomed Nanotechnol; 2010 Aug; 6(4):340-50. PubMed ID: 21323107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel core-shell nanofiber drug delivery system intended for the synergistic treatment of melanoma.
    Zhu LF; Zheng Y; Fan J; Yao Y; Ahmad Z; Chang MW
    Eur J Pharm Sci; 2019 Sep; 137():105002. PubMed ID: 31302215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimization to development of chitosan decorated polycaprolactone nanoparticles for improved ocular delivery of dorzolamide: In vitro, ex vivo and toxicity assessments.
    Shahab MS; Rizwanullah M; Alshehri S; Imam SS
    Int J Biol Macromol; 2020 Nov; 163():2392-2404. PubMed ID: 32979440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of chitosan-carboxymethyl dextran nanoparticles as a drug carrier and as a stimulator of mouse splenocytes.
    Lin YS; Radzi R; Morimoto M; Saimoto H; Okamoto Y; Minami S
    J Biomater Sci Polym Ed; 2012; 23(11):1401-20. PubMed ID: 21740648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of galactosylated chitosan/5-fluorouracil nanoparticles and its characteristics, in vitro and in vivo release studies.
    Cheng M; Han J; Li Q; He B; Zha B; Wu J; Zhou R; Ye T; Wang W; Xu H; Hou Y
    J Biomed Mater Res B Appl Biomater; 2012 Nov; 100(8):2035-43. PubMed ID: 22865703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wheat germ agglutinin-conjugated chitosan-Ca-alginate microparticles for local colon delivery of 5-FU: development and in vitro characterization.
    Glavas Dodov M; Calis S; Crcarevska MS; Geskovski N; Petrovska V; Goracinova K
    Int J Pharm; 2009 Nov; 381(2):166-75. PubMed ID: 19580856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-Fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer.
    Ortiz R; Prados J; Melguizo C; Arias JL; Ruiz MA; Alvarez PJ; Caba O; Luque R; Segura A; Aránega A
    Int J Nanomedicine; 2012; 7():95-107. PubMed ID: 22275826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of penetration potential of pH responsive double walled biodegradable nanogels coated with eucalyptus oil for the controlled delivery of 5-fluorouracil: In vitro and ex vivo studies.
    Sahu P; Kashaw SK; Jain S; Sau S; Iyer AK
    J Control Release; 2017 May; 253():122-136. PubMed ID: 28322977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanoparticles of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) for cancer chemotherapy: preparation, characterization--in-vitro drug release and anti-tumour activity.
    Yan C; Chen D; Gu J; Qin J
    J Pharm Pharmacol; 2006 Sep; 58(9):1177-81. PubMed ID: 16945175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation of polysaccharide derivates chitosan-graft-poly(ɛ-caprolactone) amphiphilic copolymer micelles for 5-fluorouracil drug delivery.
    Gu C; Le V; Lang M; Liu J
    Colloids Surf B Biointerfaces; 2014 Apr; 116():745-50. PubMed ID: 24529474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polyelectrolyte three layer nanoparticles of chitosan/dextran sulfate/chitosan for dual drug delivery.
    Wang F; Li J; Tang X; Huang K; Chen L
    Colloids Surf B Biointerfaces; 2020 Jun; 190():110925. PubMed ID: 32155455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Di-Block PLCL and Tri-Block PLCLG Matrix Polymeric Nanoparticles Enhanced the Anticancer Activity of Loaded 5-Fluorouracil.
    Ashour AE; Badran MM; Kumar A; Rishi AK; Yassin AE
    IEEE Trans Nanobioscience; 2016 Oct; 15(7):739-747. PubMed ID: 28029617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
    Gupta NK; Tomar P; Sharma V; Dixit VK
    Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycyrrhetinic acid-modified chitosan nanoparticles enhanced the effect of 5-fluorouracil in murine liver cancer model via regulatory T-cells.
    Cheng M; Xu H; Wang Y; Chen H; He B; Gao X; Li Y; Han J; Zhang Z
    Drug Des Devel Ther; 2013; 7():1287-99. PubMed ID: 24187487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlations between thymidylate synthase expression and chemosensitivity to 5-fluorouracil, cell proliferation and clinical outcome in head and neck squamous cell carcinoma.
    Yasumatsu R; Nakashima T; Uryu H; Ayada T; Wakasaki T; Kogo R; Masuda M; Fukushima M; Komune S
    Chemotherapy; 2009; 55(1):36-41. PubMed ID: 19023200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chitosan/carbon quantum dot/aptamer complex as a potential anticancer drug delivery system towards the release of 5-fluorouracil.
    Zavareh HS; Pourmadadi M; Moradi A; Yazdian F; Omidi M
    Int J Biol Macromol; 2020 Dec; 165(Pt A):1422-1430. PubMed ID: 32987067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chitosan-polycaprolactone blend sponges for management of chronic osteomyelitis: A preliminary characterization and in vitro evaluation.
    Pawar V; Srivastava R
    Int J Pharm; 2019 Sep; 568():118553. PubMed ID: 31344444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formulation, characterization and in vitro release study of 5-fluorouracil loaded chitosan nanoparticles.
    Samy M; Abd El-Alim SH; Rabia AEG; Amin A; Ayoub MMH
    Int J Biol Macromol; 2020 Aug; 156():783-791. PubMed ID: 32320805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding the role of colon-specific microparticles based on retrograded starch/pectin in the delivery of chitosan nanoparticles along the gastrointestinal tract.
    Dos Santos AM; Meneguin AB; Akhter DT; Fletcher N; Houston ZH; Bell C; Thurecht KJ; Gremião MPD
    Eur J Pharm Biopharm; 2021 Jan; 158():371-378. PubMed ID: 33309846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.